Investigación de Mercado de Turismo Médico

El turismo médico es una industria en crecimiento en todo el mundo debido al aumento de los costos de los tratamientos de salud en los países de origen, la globalización de la industria de la salud y el creciente acceso a trabajadores médicos calificados en todo el mundo. Los países de los mercados emergentes están dando prioridad a esta industria para atraer turistas médicos e impulsar las exportaciones de industrias de servicios avanzados, como los sectores sanitario, biotecnológico y farmacéutico.

Turismo Médico se define como el proceso de viajar fuera del país de residencia para recibir atención médica. Aunque muchos identifican al turismo médico como personas que viajan desde países ricos a países en desarrollo para recibir atención médica más barata, el proceso también se aplica a la situación opuesta en la que personas de países menos desarrollados viajan a economías ricas para realizar operaciones que no se realizan fácilmente en sus países de origen. .

SIS analiza todas las oportunidades potenciales que trae esta forma de trabajar y cómo los clientes y proveedores potenciales pueden prosperar y mejorar los tratamientos.

About the Medical Tourism Market

El Turismo Médico está presente en casi todos los países del mundo. Por ejemplo, los residentes estadounidenses viajan a México, Canadá o los países de América Central y del Sur para obtener atención médica más barata, mientras que los europeos viajan fuera de la UE o entre países donde los precios son más bajos.

Algunos de los destinos más populares son Cuba, Grecia, Tailandia, Corea y Serbia porque sus médicos y especialistas se encuentran entre los mejores del mundo.

Las razones más comunes por las que las personas viajan a otro país para recibir atención médica son:

1. Precio (muchas personas viajan a otros países porque no pueden pagar un seguro médico por su cuenta o porque los costos del procedimiento están muy por encima de su presupuesto, por lo que podemos concluir que este es el principal motivo del turismo médico)
2. La legalidad del servicio (algunos servicios de salud como el aborto o la eutanasia están prohibidos por ley en algunos países, pero no en todos)
   Diferencias culturales (muchos inmigrantes quieren ser tratados en su país de origen debido a sus creencias religiosas)
3. Acceso a procedimientos experimentales.
4. Acceso a una atención de mayor calidad

Entre los procedimientos que las personas deciden ir a otro país se encuentran (pero no se limitan a): tratamientos de fertilidad (por ejemplo, gestación subrogada, FIV y tecnologías de reproducción asistida), trasplantes de órganos, cirugía plástica, atención dental y tratamientos experimentales contra el cáncer.

Investigación de mercado del recorrido del cliente can uncover numerous sources of competitive advantage in the Medical Tourism sector. Customers face numerous benefits and risks in medical tourism and the stakes can be high. Before patients decide to have their procedure done in a foreign country, they often conduct comprehensive in-person and online research to pick the right facility, treatment and medical provider for his or her needs. As these decisions can be outside their domestic medical establishments, the online research that patients conduct is important in their decision making. Furthermore, people who opt for medical tourism often exhaust all available medical treatment options in their home country so they can be a vulnerable group requiring information about benefits and risks. Market Research provides the insight for Medical Tourism providers to better serve potential patients.

Las complicaciones más comunes del turismo médico incluyen:

1. Enfermedades y riesgo de infecciones: desde complicaciones de procedimientos (heridas o infecciones derivadas de donantes) hasta enfermedades infecciosas si una persona viaja a países lejanos.
2. Resistencia a los antibióticos: este es un riesgo relativamente raro, pero todo turista médico debe ser consciente de ello.
3. Problemas con la comunicación: solo los centros registrados pueden proporcionar al personal conocimientos avanzados del idioma inglés o del idioma nativo del paciente, lo cual es esencial para una atención adecuada.
4. Viajes aéreos: si los pacientes vuelan inmediatamente después de la cirugía, corren un alto riesgo de sufrir coágulos sanguíneos u otros riesgos de viaje, por lo que es aconsejable esperar al menos entre 10 y 14 días antes de regresar a casa.

Medical Investigación de Mercado Turístico: How Leading Operators Build Cross-Border Patient Pipelines

Medical tourism market research has shifted from descriptive country profiling to operational intelligence that informs corridor selection, payer partnerships, and clinical specialty positioning. The sophisticated buyers in this category, hospital networks, sovereign health funds, insurer-employer coalitions, and private equity-backed specialty groups, treat patient flow modeling the way airlines treat route economics.

The global cross-border patient market spans elective orthopedics, oncology second opinions, fertility, dental, cardiac, and bariatric procedures. Each travels along distinct corridors with distinct economics. Mexico-US dental and bariatric flows behave nothing like Gulf-to-Germany oncology referrals or China-to-Japan precision medicine cases. Treating them as a single market produces unusable forecasts.

Why Corridor-Level Medical Tourism Market Research Outperforms Country Reports

Country-level sizing obscures the unit of competition. Patients do not choose Thailand. They choose a specific Bangkok hospital with JCI accreditation, a named surgeon, an English-speaking concierge, and a payer arrangement that covers travel. Corridor analysis isolates origin-destination pairs and decomposes them into procedure mix, payer source, facilitator margin, and length-of-stay economics.

The leading operators model corridors the way logistics firms model lanes. Singapore-Indonesia cardiac. Turkey-UK hair restoration and dental. Costa Rica-US dental and orthopedics. Korea-China aesthetic surgery. India-East Africa oncology. Each corridor has a distinct conversion funnel from inquiry to deposit to arrival to follow-up, and the leakage points differ.

According to SIS International Research, the operators winning share in mature corridors invest heavily in pre-arrival clinical triage, often a structured remote consultation that qualifies the patient and pre-builds the care plan. This single step compresses on-site length of stay, reduces clinical surprises, and lifts deposit-to-arrival conversion materially above facilitator-led alternatives.

The Five Forces Reshaping Cross-Border Patient Flows

Five structural forces govern where the next decade of growth concentrates. Each is measurable and each rewards firms that build proprietary intelligence rather than rely on syndicated reports.

Payer integration. Self-funded US employers, UK NHS overflow contracting, and Gulf state-sponsored programs have moved from pilot to procurement. The buyer is no longer the patient. It is a benefits committee or a sovereign health authority running an RFP with bundled-price expectations and outcomes reporting requirements.

Accreditation as table stakes. JCI, Temos, and ISO 9001 certifications no longer differentiate. The differentiator is publishing risk-adjusted outcomes by surgeon and procedure, the standard set by Bumrungrad, Anadolu Medical Center, and Apollo Hospitals.

Facilitator disintermediation. Hospitals with mature international patient departments, Gleneagles, Asan Medical Center, Hospital Israelita Albert Einstein, are building direct payer relationships and bypassing traditional facilitators on high-margin cases.

Telemedicine pre-screening. Remote second opinions have become the top of the funnel. The hospital that captures the second opinion captures a disproportionate share of conversions.

Visa, currency, and geopolitical friction. Corridor economics shift quickly with visa policy and exchange rates. Turkey’s lira depreciation rebuilt its dental and aesthetic corridors within two years. Sanctions and travel restrictions can collapse a corridor in a quarter.

What Sophisticated Medical Tourism Market Research Actually Measures

Descriptive market sizing is the entry-level deliverable. The intelligence that informs capital allocation goes deeper.

Source: SIS International Research

The patient journey layer is where most market entry decks are weakest. Cross-border patients make decisions across an eight-to-fourteen-week window with multiple household stakeholders, and the conversion-killing moments are rarely clinical. They are visa anxiety, deposit refund policy ambiguity, and post-arrival communication gaps.

The SIS Approach to Medical Tourism Market Research

SIS International’s healthcare practice combines structured B2B expert interviews with international patient department directors, ethnographic research with returning patients, and competitive intelligence on hospital pricing, accreditation, and outcomes disclosure. A recent mixed-methodology engagement targeted 200 respondents across Brazil to map inbound and outbound patient flows for a Fortune 500 healthcare client evaluating Latin American corridor expansion.

The healthcare practice has fielded patient-side and provider-side studies across China, Mexico, the United States, Germany, Korea, Singapore, and Israel, including direct CEO-level interviews with overseas medical services agencies serving outbound Chinese patients. This dual-perspective design, capturing both the originating facilitator and the receiving hospital, surfaces the pricing and commission realities that single-sided studies miss.

SIS Corridor Viability Framework

Four dimensions determine whether a corridor merits investment.

• Volume durability. Is the patient flow tied to a structural cost or capacity gap, or to a temporary currency arbitrage?
• Payer concentration. Are the buyers individuals or institutional payers with renewable contracts?
• Clinical defensibility. Does the destination have outcomes data and surgeon depth that withstand a malpractice-conscious payer audit?
• Operational maturity. Are the international patient department, concierge, billing, and follow-up workflows institutionalized or improvised?

Corridors strong on all four, Singapore cardiac, Korea oncology, Turkey dental and orthopedics, sustain investment through currency cycles. Corridors weak on payer concentration or clinical defensibility tend to be margin-thin and reputation-fragile.

Where the Market Goes Next

Three shifts will define the next phase of corridor competition. First, employer-direct contracting will move from pilot programs at large self-funded US employers into mid-market benefits design, expanding addressable demand for centers of excellence in Mexico, Costa Rica, and Colombia. Second, fertility tourism will continue to outgrow other categories as regulatory arbitrage and donor availability concentrate volume in Spain, Greece, the Czech Republic, and parts of Latin America. Third, oncology second opinions delivered remotely will become the primary acquisition channel for high-acuity cross-border cases.

SIS International’s structured expert interviews with overseas medical services agencies indicate that destination preference among high-net-worth outbound patients is driven less by price and more by perceived clinical reputation, language infrastructure, and the agency’s own relationships with named physicians at receiving hospitals. The implication for hospitals is that physician-level brand investment outperforms institutional marketing in this segment.

Medical tourism market research that informs board-level decisions does not stop at market size. It quantifies corridor durability, payer concentration, clinical defensibility, and operational readiness, and it does so with primary evidence from both ends of the patient journey.

Acerca de SIS Internacional

SIS Internacional ofrece investigación cuantitativa, cualitativa y estratégica. Proporcionamos datos, herramientas, estrategias, informes y conocimientos para la toma de decisiones. También realizamos entrevistas, encuestas, grupos focales y otros métodos y enfoques de investigación de mercado. Póngase en contacto con nosotros para su próximo proyecto de Investigación de Mercado.